Page last updated: 2024-08-17

carbostyril and Chronic Bronchitis

carbostyril has been researched along with Chronic Bronchitis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (70.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bolger, GB; Coricor, GE; Courville, CA; Dransfield, MT; Farris, RF; Lambert, JA; Li, Y; Mazur, MM; McNicholas, CM; Raju, SV; Rowe, SM; Smoot, LH; Tang, LP1
Acosta, EP; Dransfield, MT; Hathorne, H; Liu, B; Raju, SV; Reeves, G; Rowe, SM; Solomon, GM1
Chen, LA; Falagas, ME; Liu, YN; Matthew, FE; Wang, R; Zhang, L1
Keam, SJ; Perry, CM1
Allegra, L; Cazzola, M; Dionisio, P; Salvatori, E1
Dimopoulos, G; Falagas, ME; Korbila, IP; Manta, K; Siempos, II1
Aliberti, S; Allegra, L; Blasi, F; Centanni, S; Santus, P; Tarsia, P1
Singh, A1
Chang, KC; Leung, CC1
Avgeri, SG; Dimopoulos, G; Falagas, ME; Matthaiou, DK; Siempos, II1

Reviews

5 review(s) available for carbostyril and Chronic Bronchitis

ArticleYear
Gemifloxacin for the treatment of community-acquired pneumonia and acute exacerbation of chronic bronchitis: a meta-analysis of randomized controlled trials.
    Chinese medical journal, 2012, Volume: 125, Issue:4

    Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Community-Acquired Infections; Fluoroquinolones; Gemifloxacin; Humans; Naphthyridines; Pneumonia; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome

2012
Prulifloxacin: a new fluoroquinolone for the treatment of acute exacerbation of chronic bronchitis.
    Pulmonary pharmacology & therapeutics, 2006, Volume: 19 Suppl 1

    Topics: Anti-Infective Agents; Bronchitis, Chronic; Dioxolanes; Female; Fluoroquinolones; Humans; Male; Piperazines; Quinolones

2006
Macrolides, quinolones and amoxicillin/clavulanate for chronic bronchitis: a meta-analysis.
    The European respiratory journal, 2007, Volume: 29, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Bronchitis; Bronchitis, Chronic; Clavulanic Acid; Clinical Trials as Topic; Humans; Macrolides; Odds Ratio; Pulmonary Disease, Chronic Obstructive; Quinolones; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Treatment Outcome

2007
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis.
    International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:1

    Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Dioxolanes; Fluoroquinolones; Humans; Piperazines; Prodrugs; Quinolones

2007
Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:3

    Topics: Anti-Bacterial Agents; Bronchitis, Chronic; Cefixime; Clarithromycin; Humans; Quinolones; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome

2008

Trials

2 trial(s) available for carbostyril and Chronic Bronchitis

ArticleYear
Pilot evaluation of ivacaftor for chronic bronchitis.
    The Lancet. Respiratory medicine, 2016, Volume: 4, Issue:6

    Topics: Aged; Aminophenols; Bronchitis, Chronic; Chloride Channel Agonists; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Molecular Targeted Therapy; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolones; Risk Assessment; Treatment Outcome

2016
Prulifloxacin.
    Drugs, 2004, Volume: 64, Issue:19

    Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Dioxolanes; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Humans; Italy; Molecular Structure; New Zealand; Pefloxacin; Piperazines; Prodrugs; Quinolones; Urinary Tract Infections

2004

Other Studies

3 other study(ies) available for carbostyril and Chronic Bronchitis

ArticleYear
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
    American journal of respiratory cell and molecular biology, 2014, Volume: 50, Issue:3

    Topics: Aminophenols; Aminopyridines; Animals; Benzamides; Bronchi; Bronchitis, Chronic; Cells, Cultured; Cyclic AMP; Cyclopropanes; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Intestinal Secretions; Intestine, Small; Membrane Potentials; Mice; Mucociliary Clearance; Phosphodiesterase 4 Inhibitors; Quinolones; Smoke; Smoking; Time Factors

2014
Quinolones to treat acute bacterial exacerbation of chronic bronchitis in TB endemic areas: a word of caution.
    The European respiratory journal, 2007, Volume: 30, Issue:6

    Topics: Bronchitis, Chronic; Endemic Diseases; Humans; Mycobacterium tuberculosis; Quinolones; Randomized Controlled Trials as Topic; Tuberculosis

2007
Meta-analysis may not be practicable for guiding antibiotic therapy.
    The European respiratory journal, 2008, Volume: 31, Issue:4

    Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bronchitis, Chronic; Drug Therapy; Humans; Macrolides; Meta-Analysis as Topic; Pneumonia; Practice Patterns, Physicians'; Quinolones

2008